| 注册
首页|期刊导航|武警医学|横突间植骨应用于强直性脊柱炎后凸畸形矫正术的临床疗效

横突间植骨应用于强直性脊柱炎后凸畸形矫正术的临床疗效

杨云飞 夏庆福 黄立军 夏纪元 王宇

武警医学2026,Vol.37Issue(8):682-688,7.
✕
武警医学2026,Vol.37Issue(8):682-688,7.DOI:10.3969/j.issn.1004-3594.2026.08.006

横突间植骨应用于强直性脊柱炎后凸畸形矫正术的临床疗效

Clinical efficacy of intertransverse bone grafting in the correction surgery for kyphosis de-formity in ankylosing spondylitis

杨云飞 1夏庆福 1黄立军 1夏纪元 2王宇3

作者信息

  • 1. 100122,北京大望路急诊抢救医院脊柱外科
  • 2. 102208,北京积水潭医院回龙观院区脊柱外科
  • 3. 100034,北京大学第一医院骨科
  • 折叠

摘要

Abstract

Objective To explore the clinical effect of intertransverse bone grafting in the correction surgery for kyphosis de-formity in ankylosing spondylitis(AS).Methods A retrospective analysis was conducted on 24 patients with AS combined with ky-phosis who underwent posterior osteotomy correction and intertransverse process bone grafting from 2021 to 2023.The postoperative spi-nal parameters(GK,TK,LL,SVA,etc.),bone graft fusion rate,and complications were evaluated.Results The patients under-went the surgery smoothly and had good tolerance.The postoperative thoracic lordosis angle(55.50°±16.81°),lumbar lordosis angle(44.04°±13.77°),total spinal kyphosis angle(37.29°±17.42°),sagittal plane deviation[(5.49±3.87)cm]and other parameters exhibited statistically significant differences in comparison to the preoperative period(P<0.05).Subsequent follow-up of the patients revealed no substantial decline in the parameters of concern.The absence of complications,including but not limited to vascular and nerve injuries,as well as stress fractures,was noteworthy.The postoperative bone graft fusion rate was 91.6%(22/24),and there were no cases of internal fixation breakage.Conclusions Intertransverse bone grafting can effectively enhance spinal stability and re-duce the risk of postoperative correction loss.

关键词

强直性脊柱炎/脊柱后凸/脊柱截骨术/横突间植骨/骨融合率

Key words

ankylosing spondylitis/kyphosis/spinal osteotomy/intertransverse bone grafting/bone fusion rate

分类

医药卫生

引用本文复制引用

杨云飞,夏庆福,黄立军,夏纪元,王宇..横突间植骨应用于强直性脊柱炎后凸畸形矫正术的临床疗效[J].武警医学,2026,37(8):682-688,7.

基金项目

北京市昌平区"科技副总"专项(202501012012) (202501012012)

山东省科学技术厅中央引导地方科技发展资金(YDZX2024096) (YDZX2024096)

山东省高端医疗器械创新创业共同体2024年创新项目(2024-SGTTXM-002) (2024-SGTTXM-002)

北京市自然科学基金联合基金昌平重点研究专题(L244016) (L244016)

武警医学

1004-3594

访问量0
|
下载量0
段落导航相关论文